Molecular Characterization and Resistance Gene Co-occurrence in Carbapenem-Resistant Klebsiella peumoniae from a Bangkok Tertiary Hospital, Thailand
DOI:
https://doi.org/10.3855/jidc.22124Keywords:
Antimicrobial susceptibility, Molecular characteristic, Carbapenem-resistant Klebsiella pneumonia, ThailandAbstract
Introduction: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant global health concern due to its high morbidity and mortality rates and limited treatment options. We investigated the molecular characteristics and co-occurrence of resistance genes in CRKP isolates from a tertiary hospital in Bangkok, Thailand.
Methodology: Seventy-three non-repetitive CRKP isolates were collected from clinical specimens of hospitalized patients from August 2022 to January 2023. Identification was confirmed using standard microbiological tests and MALDI-TOF-MS. Antimicrobial susceptibility was assessed using the MicroScan system. PCR was employed to detect carbapenemase genes and extended-spectrum beta-lactamases (ESBLs).
Results: The study revealed a high resistance rate among the CRKP isolates to cephalosporins, aminoglycosides, fluoroquinolone, and trimethoprim/sulfamethoxazole. Of the 73 CRKP isolates, 98.6% were susceptible to tigecycline, and 46.6% remained susceptible to ceftazidime-avibactam. Molecular analysis revealed that blaOXA-48-like (93.2%) and blaNDM-1 (43.8%) were the predominant carbapenemase genes. All isolates harbored the ESBL gene blaCTX-M-15. The co-occurrence of blaOXA-48-like and blaNDM-1 was observed in 39.7% of the isolates. Ward-specific analysis revealed the highest diversity and frequency of co-resistance gene profiles in isolates from the medical ward, while isolates from ICUs also exhibited complex gene combinations involving multiple ESBL and carbapenemase genes.
Conclusions: This study reveals a high prevalence of blaOXA-48-like and blaNDM-1 genes among CRKP isolates in a tertiary hospital in Bangkok. The diversity of resistance profiles and the clustering of complex gene combinations, particularly in medical and ICU wards, underscore the need for continuous molecular surveillance and stringent infection control measures to manage the spread of CRKP in healthcare setting.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anek Pootong, Sidaporn Saiaut, Naipapron Dinmuang, Preeyanuch Wangleotsakulchai

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

